Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Key Information
Due Date: September 7, 2026
Agency: Not Specified
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This grant relates to schizophrenia and associated disorders that occur during mid to late adulthood (R01 Clinical Trial Optional). Despite the fact that most individuals diagnosed with these disorders are over the age of 35, including both newly diagnosed and those aging with the disease, our understanding of the causes and progression of these illnesses remains limited. The objective of this grant is to further translational research in an effort to gain a clearer comprehension of how schizophrenia and related disorders develop and evolve in mid to late adulthood. The ultimate goal of this initiative is to identify potential areas of focus for the future development of preventative measures and treatments.
Show More
Key Dates
Open Date: June 29, 2023
Application Due Date: September 7, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses